Anika Therapeutics (ANIK) Tops Q2 EPS by 10c, Beats on Revenue; Offers FY24 Revenue Guidance
Go back to Anika Therapeutics (ANIK) Tops Q2 EPS by 10c, Beats on Revenue; Offers FY24 Revenue Guidance| Anika Therapeutics, Inc. (NASDAQ: ANIK) | Delayed: 21.50 +0.33 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.17 | 52 Week High | $54.96 | |||
| Open | $21.17 | 52 Week Low | $35.07 | |||
| Day High | $21.98 | P/E | 17.06 | |||
| Day Low | $21.04 | EPS | $1.26 | |||
| Volume | 124,987 | |||||
